Although production of the “standard” Cadillac CT4 and Cadillac CT5 has been delayed until later next month, limited production of the high-performance Cadillac CT4-V Blackwing and Cadillac CT5-V Blackwing will continue. Production of the Chevy Camaro at the Lansing facility will continue as well.
Per a recent report from Automotive News, production stoppage of the Cadillac CT4 and Cadillac CT5 at the Lansing Grand River Assembly facility is just one of several new production stoppages arising from the ongoing global microchip shortage, which continues to impact several of General Motors’ North American production facilities.
Other facilities impacted by the shortage include the GM Ramos Arizpe plant in Mexico, which will halt production of the Chevy Blazer crossover until September 6th, as GM Authority covered previously. Production of the Chevy Equinox at the Ramos Arizpe plant will be down until September 20th.
Production of the Chevy Traverse and Buick Enclave at the Lansing Delta Township Assembly plant in Michigan is also affected, as is production of the Cadillac XT5, Cadillac XT6, and GMC Acadia at the GM Spring Hill Assembly plant, production of the Chevy Equinox at CAMI Assembly in Canada, and production of the Chevy Equinox and GMC Terrain at the San Luis Potosi plant in Mexico.
These latest production stoppages follow a long line of delays and problems this year stemming from the global microchip shortage. To help soften the blow of the shortage, General Motors has prioritized production of its most popular vehicles, including its full-size SUVs and trucks, while deleting certain features from certain models, such as AFM and DFM. What’s more, General Motors has adopted a “build-shy” strategy wherein certain models are produced in an unfinished state and parked while new chips are sourced, after which the vehicles are completed and shipped out to dealers.